Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [1837]
News [4190]
Articles [374]
Editorials [10]
Conferences [105]
elearning [28]
Pertuzumab adds 16 months survival benefit to trastuzumab plus chemotherapy for...
Dr Sandra Swain - Washington Cancer Institute, Washington, USA
Pertuzumab adds 16 months survival benefit to trastuzumab plus chemotherapy for HER2-positive metastatic breast cancer ( Dr Sandra Swain - Washington Cancer Institute, Washington, USA )
28 Sep 2014
The evolving treatment landscape for HER2-positive metastatic breast cancer
Dr Hatem Azim - Institut Jules Bordet, Brussels, Belgium
The evolving treatment landscape for HER2-positive metastatic breast cancer ( Dr Hatem Azim - Institut Jules Bordet, Brussels, Belgium )
18 Sep 2014
Navigating current treatment options for HER2-positive MBC: Patient journey 1
Dr Rupert Bartsch - Medical University of Vienna, Vienna, Austria
Navigating current treatment options for HER2-positive MBC: Patient journey 1 ( Dr Rupert Bartsch - Medical University of Vienna, Vienna, Austria )
18 Sep 2014
ecancermedicalscience editor's choice for September 2014
Prof Gordon McVie - ecancer and European Institute of Oncology, Milan, Italy
ecancermedicalscience editor's choice for September 2014 ( Prof Gordon McVie - ecancer and European Institute of Oncology, Milan, Italy )
18 Sep 2014
ecancermedicalscience editor's choice for July and August 2014
Prof Gordon McVie - ecancer and European Institute of Oncology, Milan, Italy
ecancermedicalscience editor's choice for July and August 2014 ( Prof Gordon McVie - ecancer and European Institute of Oncology, Milan, Italy )
19 Aug 2014
Metronomics and low/middle income countries, especially in breast cancer
Dr Alexandru Eniu - Cancer Institute Ion Chiricuta Cluj-Napoca, Cluj-Napoca...
Metronomics and low/middle income countries, especially in breast cancer ( Dr Alexandru Eniu - Cancer Institute Ion Chiricuta Cluj-Napoca, Cluj-Napoca, Romania )
10 Jul 2014
Drug repurposing as an alternative to costly drugs such as herceptin in breast...
Dr Shripad Banavali - Tata Memorial Hospital, Mumbai, India
Drug repurposing as an alternative to costly drugs such as herceptin in breast cancer ( Dr Shripad Banavali - Tata Memorial Hospital, Mumbai, India )
10 Jul 2014
Diabetes drug, metformin, repurposed for use against several cancers including...
Dr Francesco Bertolini - European Institute of Oncology, Milan, Italy
Diabetes drug, metformin, repurposed for use against several cancers including breast ( Dr Francesco Bertolini - European Institute of Oncology, Milan, Italy )
10 Jul 2014
Networking and collaborating across borders in sub-Saharan Africa
Dr Shubhra Ghosh - Project Director of Global Programs, MD Anderson Cancer...
Networking and collaborating across borders in sub-Saharan Africa ( Dr Shubhra Ghosh - Project Director of Global Programs, MD Anderson Cancer Centre, Houston, USA )
26 Jun 2014
Work of the WIN consortium and challenges of personalised cancer therapy
Prof John Mendelsohn - University of Texas MD Anderson Cancer Center, Houston...
Work of the WIN consortium and challenges of personalised cancer therapy ( Prof John Mendelsohn - University of Texas MD Anderson Cancer Center, Houston, USA )
26 Jun 2014
LHRH analogue goserelin helps preserve fertility among women undergoing chemo...
Dr Halle Moore - Taussig Cancer Institute, Cleveland, USA
LHRH analogue goserelin helps preserve fertility among women undergoing chemo for hormone receptor-negative breast cancer ( Dr Halle Moore - Taussig Cancer Institute, Cleveland, USA )
12 Jun 2014
Investigating anticarcinogenic compounds as an alternative to chemo
Dr Bernardo Bonnani - European Institute of Oncology, Milan, Italy
Investigating anticarcinogenic compounds as an alternative to chemo ( Dr Bernardo Bonnani - European Institute of Oncology, Milan, Italy )
6 Jun 2014

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation